| Previous close | 0.3000 |
| Open | 0.2000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 310.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1600 - 0.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Investor's Business DailyBiogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment
Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.
ZacksBiogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
© 2024 Yahoo. All rights reserved.